iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Activest Wealth Management

Activest Wealth Management reduced its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 35.4% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 852 shares of the financial services provider’s stock after selling 467 shares during the quarter. Activest Wealth Management’s holdings in iShares Biotechnology ETF were worth $124,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in IBB. Darwin Wealth Management LLC bought a new stake in iShares Biotechnology ETF during the third quarter worth approximately $29,000. Highline Wealth Partners LLC purchased a new stake in shares of iShares Biotechnology ETF during the third quarter worth $30,000. Bbjs Financial Advisors LLC acquired a new stake in shares of iShares Biotechnology ETF during the 2nd quarter valued at about $31,000. Ashton Thomas Securities LLC acquired a new position in shares of iShares Biotechnology ETF during the 3rd quarter worth $36,000. Finally, Voisard Asset Management Group Inc. bought a new position in iShares Biotechnology ETF during the third quarter valued at about $59,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

NASDAQ IBB traded down $0.21 during trading on Thursday, hitting $134.63. The company’s stock had a trading volume of 77,551 shares, compared to its average volume of 1,444,948. iShares Biotechnology ETF has a 52 week low of $117.28 and a 52 week high of $150.57. The firm has a 50 day moving average price of $143.82 and a 200 day moving average price of $141.75.

iShares Biotechnology ETF Dividend Announcement

The business also recently announced a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.